Status

137%

not available

Share

Funding data

Raised
EUR 547,302.00

Details

Country
Italy IT
Type
Equity
investors
115

Description

“L’innovativa società healthcare che utilizza tecnologie sostenibili di Plant Molecular Farming per produrre biofarmaci per malattie rare, vaccini anti-virali e anticorpi monoclonali”

Funding progress

Project preview